Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Inamoto · SciRah

Researcher profile · Semantic Scholar

T. Inamoto

Share profile

T. Inamoto — researcher profile on SciRah

h-index: 30
Works: 308
Citations: 3,230

Most-cited papers

The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
K. Komura, Kensuke Hirosuna, S. Tokushige, T. Tsujino +23 more
2023Molecular Cancer56 citations Open access
Semantic Scholar
Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents
K. Komura, T. Inamoto, T. Tsujino, Yusuke Matsui +16 more
2021Oncogene35 citations Open access
Semantic Scholar
Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab
Yusuke Yano, Takaya Ohno, K. Komura, Wataru Fukuokaya +23 more
2022Cancers20 citations Open access
Semantic Scholar
Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab
K. Komura, S. Tokushige, Mitsuaki Ishida, Kensuke Hirosuna +20 more
2023Cancer Science19 citations Open access
Semantic Scholar
Risk Classification for Overall Survival by the Neutrophil–Lymphocyte Ratio and the Number of Metastatic Sites in Patients Treated with Pembrolizumab—A Multicenter Collaborative Study in Japan
Taizo Uchimoto, K. Komura, Wataru Fukuokaya, T. Kimura +19 more
2021Cancers16 citations Open access
Semantic Scholar
Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma
T. Tsujino, K. Komura, T. Inamoto, R. Maenosono +24 more
2023World journal of urology13 citations
Semantic Scholar
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer
Kazuki Nishimura, K. Nishio, Kensuke Hirosuna, K. Komura +22 more
2022Journal for ImmunoTherapy of Cancer13 citations Open access
Semantic Scholar
Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study.
T. Nukaya, K. Takahara, A. Yoshizawa, M. Saruta +25 more
2023Clinical Genitourinary Cancer12 citations
Semantic Scholar
Unplanned hemodialysis initiation and low geriatric nutritional risk index scores are associated with end-stage renal disease outcomes
R. Maenosono, T. Fukushima, D. Kobayashi, Tomohisa Matsunaga +10 more
2022Scientific Reports12 citations Open access
Semantic Scholar
Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma.
Taizo Uchimoto, Ko Nakamura, K. Komura, Wataru Fukuokaya +17 more
2022Urologic oncology12 citations Open access
Semantic Scholar
Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors
Taizo Uchimoto, Shuya Tsuchida, K. Komura, Wataru Fukuokaya +28 more
2024Targeted oncology11 citations
Semantic Scholar
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium
Taizo Uchimoto, Kengo Iwatsuki, K. Komura, Wataru Fukuokaya +32 more
2024International Journal of Clinical Oncology11 citations
Semantic Scholar
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Taizo Uchimoto, Takuya Matsuda, K. Komura, Wataru Fukuokaya +28 more
2024Targeted oncology11 citations
Semantic Scholar
Re‐challenging chemotherapy after pembrolizumab in platinum‐refractory urothelial carcinoma
Taizo Uchimoto, T. Fukushima, K. Komura, Wataru Fukuokaya +22 more
2022BJU International9 citations
Semantic Scholar
Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinoma
Shingo Toyoda, Lan Inoki, Mamoru Hashimoto, Wataru Fukuokaya +13 more
2026Scientific Reports8 citations Open access
Semantic Scholar
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival
Keita Nakamori, Shogo Yamazaki, K. Komura, Wataru Fukuokaya +22 more
2022Clinical and Translational Radiation Oncology7 citations Open access
Semantic Scholar
Current Kidney‐Preserving Strategies for Upper Tract Urothelial Carcinoma
T. Inamoto, Shunsuke Watanabe, Yoshihiro Tsuchiya, Gaku Ishikawa +7 more
2025International journal of urology5 citations
Semantic Scholar
Comparing Perioperative Outcomes Using Single and Multiple Robot Systems During the Learning Period for Robot-Assisted Radical Prostatectomy.
Y. Matsushita, Yoshihiro Tsuchiya, Gaku Ishikawa, A. Sano +8 more
2025Asian Journal of Endoscopic Surgery5 citations
Semantic Scholar
Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy
M. Miyake, Kota Iida, N. Nishimura, Takashi Inoue +18 more
2022European Urology Open Science5 citations Open access
Semantic Scholar
Early Prostate-Specific Antigen (PSA) Change at Four Weeks of the First-Line Treatment Using Abiraterone and Enzalutamide Could Predict Early/Primary Resistance in Metastatic Castration-Resistant Prostate Cancer
Taizo Uchimoto, K. Komura, Wataru Fukuokaya, T. Kimura +19 more
2021Cancers5 citations Open access
Semantic Scholar
Comparison of Perioperative Outcomes for Complex Renal Tumors Between the Da Vinci and Hinotori Surgical Robot System During Robot-Assisted Partial Nephrectomy: A Propensity Score Matching Analysis
D. Motoyama, Kyohei Watanabe, Y. Matsushita, H. Watanabe +3 more
2025Journal of Clinical Medicine4 citations Open access
Semantic Scholar
Comparing oncological outcomes and safety between photodynamic diagnosis-assisted and white-light transurethral resection in elderly patients with non-muscle invasive bladder cancer.
Y. Matsushita, Yoshihiro Tsuchiya, Gaku Ishikawa, A. Sano +8 more
2025Japanese Journal of Clinical Oncology4 citations
Semantic Scholar
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium.
Taizo Uchimoto, Kensuke Hirosuna, Heima Niigawa, Sho Kakumae +26 more
2025Japanese Journal of Clinical Oncology4 citations
Semantic Scholar
Comparing Immuno-oncology Combination Therapy With Tyrosine Kinase Inhibitor Monotherapy for Advanced Renal Cell Carcinoma
Gaku Ishikawa, K. Tamura, Yoshihiro Tsuchiya, Shunsuke Watanabe +8 more
2024Anticancer Research4 citations
Semantic Scholar
A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium
T. Yanagisawa, K. Mori, Tatsushi Kawada, Satoshi Katayama +17 more
2026Cancer Immunology and Immunotherapy3 citations Open access
Semantic Scholar
Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysis.
Kazuki Nishimura, Kensuke Hirosuna, Heima Niigawa, Sho Kakumae +26 more
2026Japanese Journal of Clinical Oncology3 citations
Semantic Scholar
Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial Carcinoma
Kyosuke Nishio, Kensuke Hirosuna, Taizo Uchimoto, Heima Niigawa +24 more
2025Anticancer Research3 citations
Semantic Scholar
Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma.
T. Inamoto, Ryo Sato, Y. Matsushita, Taizo Uchimoto +15 more
2023Cancer Diagnosis & Prognosis3 citations Open access
Semantic Scholar
Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver Metastases
Kyosuke Nishio, Takuya Higashio, K. Komura, Wataru Fukuokaya +24 more
2023Oncology3 citations
Semantic Scholar
Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer
T. Tsujino, S. Tokushige, K. Komura, Wataru Fukuokaya +23 more
2023Cancer Medicine3 citations Open access
Semantic Scholar
A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer
T. Tsujino, Shogo Yamazaki, M. Sakamoto, Yuki Yoshikawa +31 more
2026Signal Transduction and Targeted Therapy2 citations Open access
Semantic Scholar
LC-MS/MS and high-spatial single-cell MSI reveal selective downregulation of PC(16:0_16:0) and PC(18:0_18:1) due to mPGES-1 knockdown in hormone-resistant prostate cancer cell line
Mst. Sayela Afroz, Shuhei Aramaki, Md Muedur Rahman, M. Dubail +10 more
2025Analytical and Bioanalytical Chemistry2 citations Open access
Semantic Scholar
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma
Kazuki Nishimura, K. Takahara, K. Komura, Mitsuaki Ishida +15 more
2024npj Precision Oncology2 citations Open access
Semantic Scholar
Usefulness of Dietary Salt Restriction in Kidney Transplant Recipients: Analysis of Blood Pressure Levels Depending on the Differences in the Levels of Salt Intake.
H. Hirano, Y. Fujiwara, R. Maenosono, K. Minami +7 more
2023Transplantation Proceedings2 citations Open access
Semantic Scholar
Real‐world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST‐NIVO study): 36‐month follow‐up results of a clinical chart review
J. Yonese, Nobuyuki Hinata, S. Masui, Y. Nakai +16 more
2023International journal of urology2 citations Open access
Semantic Scholar
Significance of second progression‐free survival in patients with advanced urothelial cancer who received platinum‐based combination chemotherapy followed by pembrolizumab
Ryo Sato, T. Inamoto, Y. Matsushita, Ayana Takemura +13 more
2022International journal of urology2 citations Open access
Semantic Scholar
Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell Carcinoma.
Lan Inoki, Shingo Toyoda, Wataru Fukuokaya, T. Yanagisawa +10 more
2026Clinical Genitourinary Cancer1 citations
Semantic Scholar
Comparative Efficacy of First‐Line Immune Checkpoint Inhibitor‐Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study
K. Tamura, Y. Matsushita, H. Watanabe, T. Yanagisawa +12 more
2026International journal of urology1 citations Open access
Semantic Scholar
The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone‐Sensitive Prostate Cancer Treated With First‐Line ARPI Therapy
Takeshi Tsutsumi, Shogo Yamazaki, Takuya Matsuda, T. Tsujino +24 more
2026The Prostate1 citations Open access
Semantic Scholar
Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinoma.
Takafumi Minami, Shingo Toyoda, Mamoru Hashimoto, Wataru Fukuokaya +11 more
2026Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Oncological Outcomes and Prognostic Factors of Platinum‐Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum‐Based Chemotherapy Alone: A Propensity Score–Matched Analysis in a Real‐World Population
Y. Matsushita, Y. Kita, Shoichioro Mukai, Akira Joraku +16 more
2026International journal of urology1 citations Open access
Semantic Scholar
Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study
Koichi Sugimoto, Shingo Toyoda, Lan Inoki, K. Mori +12 more
2026International Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxel.
Taizo Uchimoto, Kensuke Hirosuna, Heima Niigawa, Taisuke Jo +24 more
2026Japanese Journal of Clinical Oncology1 citations
Semantic Scholar
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score’s impact
T. Fukushima, T. Tsujino, M. Sakamoto, Kiyoshi Takahara +29 more
2025World journal of urology1 citations
Semantic Scholar
Impact of Estimated Glomerular Filtration Rate and Serum C‐Reactive Protein Level to Overall Survival After Second‐Line Targeted Therapy Following Immuno‐Oncology Combination Therapy for Advanced Renal Cell Carcinoma
K. Nakane, H. Watanabe, T. Naiki, Kiyoshi Takahara +5 more
2025International journal of urology1 citations
Semantic Scholar
Use of Preoperative Renal Volumetry to Predict Postdonation Renal Function With Inulin Clearance as Indicator in Japan.
A. Sano, Takayuki Sugiyama, Shinsuke Isobe, Yoshihiro Tsuchiya +10 more
2025Transplantation Proceedings1 citations Open access
Semantic Scholar
[A CASE OF SEVERE DRUG INDUCED ERUPTION AFTER APALUTAMIDE USE FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER, WHICH WAS DETERIORATED FROM TEMPORARY REMISSION AFTER DRUG WITHDRAWAL].
Baku Iijima, T. Inamoto, Hirofumi Uehara, K. Komura +1 more
2024Nihon Hinyokika Gakkai zasshi. The japanese journal of urology1 citations Open access
Semantic Scholar
Importance of Management of Lifestyle-Related Diseases After Kidney Donation to Living Donors.
H. Hirano, Y. Fujiwara, Tomota Okabe, Keita Nakamori +6 more
2024Transplantation Proceedings1 citations Open access
Semantic Scholar
A case of renomedullary interstitial cell tumor: Radiologic-pathologic correlation
Kiyohito Yamamoto, Shigeru Kawabata, Yoshitaka Kurisu, T. Inamoto +2 more
2023Radiology Case Reports1 citations Open access
Semantic Scholar
Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer
Atsushi Ichihasi, T. Inamoto, Taizo Uchimoto, Ko Nakamura +17 more
2023In Vivo1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Komura×38
Invite
K. Komura — researcher profile on SciRah
T. Tsujino×29
Invite
T. Tsujino — researcher profile on SciRah
Kazuki Nishimura×27
Invite
Kazuki Nishimura — researcher profile on SciRah
R. Maenosono×24
Invite
R. Maenosono — researcher profile on SciRah

×24

Invite

Taizo Uchimoto — researcher profile on SciRah

Wataru Fukuokaya×23

Invite

Wataru Fukuokaya — researcher profile on SciRah

Invite

H. Azuma — researcher profile on SciRah

T. Yanagisawa×21

Invite

T. Yanagisawa — researcher profile on SciRah

Keita Nakamori×20

Invite

Keita Nakamori — researcher profile on SciRah

K. Takahara×18

Invite

K. Takahara — researcher profile on SciRah

Haruhito Azuma×17

Invite

Haruhito Azuma — researcher profile on SciRah

Invite

F. Urabe — researcher profile on SciRah